Inozyme Pharma News

Inozyme Pharma Analyst Ratings

BenzingaApr 9 07:53 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Inozyme Pharma (INZY), Zai Lab (ZLAB) and Idexx Laboratories (IDXX)

TipRanksApr 9 06:20 ET

Analysts Offer Insights on Healthcare Companies: Syndax Pharmaceuticals (SNDX), Inozyme Pharma (INZY) and PTC Therapeutics (PTCT)

TipRanksApr 9 05:40 ET

Buy Rating for Inozyme Pharma Backed by Promising Clinical Progress and Unique Market Positioning of INZ-701

TipRanksMar 13 06:16 ET

Inozyme Pharma: Strong Buy Rating Amidst Promising Trial Developments and Market Underappreciation

TipRanksMar 12 12:45 ET

Inozyme Pharma Analyst Ratings

BenzingaMar 12 12:34 ET

Inozyme Pharma Analyst Ratings

BenzingaJan 30 10:49 ET

Needham Reiterates Buy on Inozyme Pharma, Maintains $23 Price Target

BenzingaNov 8, 2023 04:52 ET

Inozyme Pharma Analyst Ratings

BenzingaNov 8, 2023 04:51 ET

TD Cowen Reaffirms Their Buy Rating on Inozyme Pharma (INZY)

TipRanksNov 7, 2023 16:26 ET

Needham Reiterates Buy on Inozyme Pharma, Maintains $23 Price Target

BenzingaSep 27, 2023 06:31 ET

Inozyme Pharma Analyst Ratings

BenzingaSep 27, 2023 06:30 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Inozyme Pharma (INZY), Ionis Pharmaceuticals (IONS) and Cano Health (CANO)

TipRanksSep 26, 2023 21:10 ET

Positive Clinical Trial Updates Boost Inozyme Pharma's Buy Rating: Efficacy of INZ-701 in ENNP1 and ABCC6 Deficiencies

TipRanksSep 26, 2023 21:10 ET

Promising Trial Results and Financial Stability Bolster Buy Rating for Inozyme Pharma's Stock (INZY)

TipRanksSep 26, 2023 12:25 ET

Wedbush Maintains Outperform on Inozyme Pharma, Announces $15 Price Target

BenzingaSep 8, 2023 11:00 ET

Inozyme Pharma Analyst Ratings

BenzingaSep 8, 2023 10:59 ET

HC Wainwright & Co. Reiterates Buy on Inozyme Pharma, Maintains $16 Price Target

BenzingaAug 8, 2023 12:24 ET

Inozyme Pharma Analyst Ratings

BenzingaAug 8, 2023 12:23 ET

Inozyme Pharma Analyst Ratings

BenzingaAug 4, 2023 12:51 ET